128 related articles for article (PubMed ID: 26060763)
1. Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
Saei M; Holakouie-Naieni K; Mostafavi E; Sahraian MA; Mahmoodi M; Mansournia MA; Hosseini A
Iran J Public Health; 2014 May; 43(5):621-9. PubMed ID: 26060763
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.
Eskandarieh S; Heydarpour P; Elhami SR; Sahraian MA
Iran J Public Health; 2017 May; 46(5):699-704. PubMed ID: 28560202
[TBL] [Abstract][Full Text] [Related]
3. Potential impact of air pollution on multiple sclerosis in Tehran, Iran.
Heydarpour P; Amini H; Khoshkish S; Seidkhani H; Sahraian MA; Yunesian M
Neuroepidemiology; 2014; 43(3-4):233-8. PubMed ID: 25501708
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
[TBL] [Abstract][Full Text] [Related]
5. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
6. Diffusion of interferon beta in Iran and its utilization in Tehran.
Palesh M; Jonsson PM; Jamshidi H; Wettermark B; Tomson G; Fredrikson S
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):934-41. PubMed ID: 18509835
[TBL] [Abstract][Full Text] [Related]
7. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
8. A description of spatial-temporal patterns of the novel COVID-19 outbreak in the neighbourhoods' scale in Tehran, Iran.
Lak A; Maher A; Zali A; Badr S; Mostafavi E; Baradaran HR; Hanani K; Toomanian A; Khalili D
Med J Islam Repub Iran; 2021; 35():128. PubMed ID: 35321381
[No Abstract] [Full Text] [Related]
9. New framework of Getis-Ord's indexes associating spatial autocorrelation with interaction.
Chen Y
PLoS One; 2020; 15(7):e0236765. PubMed ID: 32730303
[TBL] [Abstract][Full Text] [Related]
10. Spatio-temporal analysis of Pertussis using geographic information system among Iranian population during 2012-2018.
Alimohamadi Y; Zahraei SM; Karami M; Yaseri M; Lotfizad M; Holakouie-Naieni K
Med J Islam Repub Iran; 2020; 34():22. PubMed ID: 32551311
[No Abstract] [Full Text] [Related]
11. Equity Chasm in Megacities: Five Leading Causes of Death in Tehran.
Gohari K; Parsaeian M; Sheidaei A; Rahimzadeh S; Baghestani AR; Pourhoseingholi MA; Pazhuheian F; Saeedi Moghaddam S; Mansouri A; Naderimagham S; Kavousi A; Farzadfar F
Arch Iran Med; 2015 Oct; 18(10):622-8. PubMed ID: 26443245
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2020 Aug; 43():102178. PubMed ID: 32417663
[TBL] [Abstract][Full Text] [Related]
13. A spatio-temporal analysis of influenza-like illness in Iran from 2011 to 2016.
Panahi MH; Parsaeian M; Mansournia MA; Khoshabi M; Gouya MM; Hemati P; Fotouhi A
Med J Islam Repub Iran; 2020; 34():65. PubMed ID: 32974231
[No Abstract] [Full Text] [Related]
14. The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.
Ezabadi SG; Ayoubi S; Sahraian MA; Omrani MA; Eskandarieh S
Neurol Sci; 2023 Dec; 44(12):4517-4518. PubMed ID: 37642789
[TBL] [Abstract][Full Text] [Related]
15. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
16. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
[TBL] [Abstract][Full Text] [Related]
18. The Geographical Distribution of Probable COVID-19 Patients Transferred by Tehran Emergency Medical Services; a Cross Sectional Study.
Saberian P; Rafiemanesh H; Sadeghi M; Hasani-Sharamin P; Dadashi F; Baratloo A
Arch Acad Emerg Med; 2021; 9(1):e25. PubMed ID: 34027420
[TBL] [Abstract][Full Text] [Related]
19. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
20. A comparison of food pattern, macro- and some micronutrients density of the diet across different socio-economic zones of Tehran.
Abdollahi M; Salehi F; Kalantari N; Asadilari M; Khoshfetrat MR; Ajami M
Med J Islam Repub Iran; 2016; 30():340. PubMed ID: 27390710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
